November 14, 2020
From the event website:
Over the last several years, a renaissance in psychedelic research has begun to transform the study of human consciousness and its role in mental illness. In randomized clinical trials, psychedelic-assisted therapies have shown promise in the treatment of multiple psychiatric disorders, with both MDMA and psilocybin receiving a “breakthrough therapy” designation from the FDA. This course will provide an overview of contemporary psychedelic research, including naturalistic studies, clinical trials of psychedelic-assisted psychotherapy, and cutting-edge basic science research. The course will be of interest to clinicians and researchers alike, highlighting the need for collaboration across disciplines as this field continues to grow.
For more information, visit the event website.